This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Valeo Pharma Gestione
Gestione criteri di controllo 0/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Al Moghaddam
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | 1.6yrs |
| Durata media del Consiglio di amministrazione | 1.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost
Jun 14
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower
Apr 20Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing
Mar 02Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump
Jan 17Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%
Jun 08Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%
Jun 24Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts
Jun 17Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?
Feb 08AMMINISTRATORE DELEGATO
Al Moghaddam (57 yo)
less than a year
Mandato
Mr. Al Moghaddam, B. Com. CMA had been a Director at Valeo Pharma Inc. since March 21, 2024 until June 2024 and served as its Chief Development Officer since June 2024 until August 2024 and serves as its C...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Senior VP & Chief Commercial Officer | 2.3yrs | CA$388.21k | 0.020% CA$ 872.5 | |
| Chief Executive Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
| Director of Communications & Investor Relations | no data | Nessun dato | Nessun dato | |
| VP of Legal Affairs & Corporate Secretary | no data | Nessun dato | 0% CA$ 0 | |
| Head of Ophthalmology Business Unit | 2.3yrs | Nessun dato | Nessun dato |
1.6yrs
Durata media
Gestione esperta: Il team dirigenziale di VPH non è considerato esperto (durata media 1.6 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Independent Director | less than a year | Nessun dato | 0.18% CA$ 7.9k | |
| Chairman of the Advisory Board & Director | 15.8yrs | Nessun dato | 16.44% CA$ 730.0k | |
| Chairman | 21.7yrs | CA$466.29k | 0.18% CA$ 8.1k | |
| Independent Non-Executive Director | 2.6yrs | Nessun dato | 2.36% CA$ 104.9k | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | less than a year | Nessun dato | Nessun dato |
1.8yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di VPH non è considerato esperto (durata media del mandato 1.8 anni), il che suggerisce un nuovo consiglio.